These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 9582616)
21. Melatonin as biological response modifier in cancer patients. Neri B; de Leonardis V; Gemelli MT; di Loro F; Mottola A; Ponchietti R; Raugei A; Cini G Anticancer Res; 1998; 18(2B):1329-32. PubMed ID: 9615811 [TBL] [Abstract][Full Text] [Related]
22. Inhibitory effect of interleukin-3 on interleukin-2-induced cortisol release in the immunotherapy of cancer. Lissoni P; Rovelli F; Tancini G; Tisi E; Rivolta MR; Ardizzoia A; Brivio F J Biol Regul Homeost Agents; 1992; 6(4):113-5. PubMed ID: 1338354 [TBL] [Abstract][Full Text] [Related]
23. Endocrine effects of erythropoietin in cancer patients. Lissoni P; Perego M; Veronese E; Fumagalli G; Brivio F; Colciago M; Messina G; Rovelli F; Brivio R; Gardani G Hematology; 2004; 9(5-6):363-7. PubMed ID: 15763975 [TBL] [Abstract][Full Text] [Related]
24. A psychoncological study of lymphocyte subpopulations in relation to pleasure-related neurobiochemistry and sexual and spiritual profile to Rorschach's test in early or advanced cancer patients. Messina G; Lissoni P; Bartolacelli E; Tancini G; Villa S; Gardani GS; Brivio F J Biol Regul Homeost Agents; 2003; 17(4):322-6. PubMed ID: 15065761 [TBL] [Abstract][Full Text] [Related]
25. Physiopathology of IL-12 in human solid neoplasms: blood levels of IL-12 in early or advanced cancer patients, and their variations with surgery and immunotherapy. Lissoni P; Mengo S; Mandalà M; Mauri E; Brivio F; Rovelli F; Confalonieri G; Longarini R; Bonfante A; Folli D; Meregalli S; Barni S; Tancini G; Giani L J Biol Regul Homeost Agents; 1998; 12(1-2):38-41. PubMed ID: 9677534 [TBL] [Abstract][Full Text] [Related]
26. Short term changes in melatonin and cortisol serum levels after a single administration of estrogen to menopausal women. Kerdelhué B; Andrews MC; Zhao Y; Scholler R; Jones HW Neuro Endocrinol Lett; 2006 Oct; 27(5):659-64. PubMed ID: 17159819 [TBL] [Abstract][Full Text] [Related]
27. Endocrine effects of the H2-receptor antagonists cimetidine and ranitidine. Barbara L; Corinaldesi R; Pasquali R; Raiti C; Zurita J; Stanghellini V Int J Tissue React; 1983; 5(4):387-92. PubMed ID: 6323339 [TBL] [Abstract][Full Text] [Related]
28. Neuroendocrine alterations in lung cancer patients. Mazzoccoli G; Carughi S; De Cata A; La Viola M; Giuliani A; Tarquini R; Perfetto F Neuro Endocrinol Lett; 2003; 24(1-2):77-82. PubMed ID: 12743538 [TBL] [Abstract][Full Text] [Related]
29. A study of light/dark rhythm of melatonin in relation to cortisol and prolactin secretion in schizophrenia. Viganò D; Lissoni P; Rovelli F; Roselli MG; Malugani F; Gavazzeni C; Conti A; Maestroni G Neuro Endocrinol Lett; 2001 Apr; 22(2):137-41. PubMed ID: 11335890 [TBL] [Abstract][Full Text] [Related]
30. Effects of IL-2 preoperative immunotherapy on surgery-induced changes in angiogenic regulation and its prevention of VEGF increase and IL-12 decline. Brivio F; Lissoni P; Rovelli F; Nespoli A; Uggeri F; Fumagalli L; Gardani G Hepatogastroenterology; 2002; 49(44):385-7. PubMed ID: 11995457 [TBL] [Abstract][Full Text] [Related]
31. Sensitive detection of the endocrine effects of the estrogen analogue ethinylestradiol using a modified enhanced subacute rat study protocol (OECD Test Guideline no. 407). Andrews P; Freyberger A; Hartmann E; Eiben R; Loof I; Schmidt U; Temerowski M; Folkerts A; Stahl B; Kayser M Arch Toxicol; 2002 May; 76(4):194-202. PubMed ID: 12029382 [TBL] [Abstract][Full Text] [Related]
32. Acute effects of various chemotherapeutic combinations on hypophyseal and pineal hormone secretions in cancer patients. Barni S; Lissoni P; Tancini G; Crispino S; Paolorossi F; Rovelli F; Fumagalli G; Ferri L; Esposti D; Esposti G Tumori; 1987 Apr; 73(2):181-5. PubMed ID: 2953096 [TBL] [Abstract][Full Text] [Related]
33. [Endocrine changes of the liver in the cirrhotic alcoholic: analysis of circadian rhythms of anteriopituitary, adrenocortical, and gonadal hormones]. Pasqualetti P; Colantonio D; Casale R; Natali G Riv Eur Sci Med Farmacol; 1989 Jun; 11(3):227-35. PubMed ID: 2640044 [TBL] [Abstract][Full Text] [Related]
34. A comparison of systemic versus inhaled recombinant IL-2 administration for the treatment of metastatic renal cell carcinoma. Huland E; Heinzer H; Huland H Folia Biol (Praha); 2000; 46(6):241-50. PubMed ID: 11140857 [TBL] [Abstract][Full Text] [Related]
35. The hypothalamic-pituitary-thyroid axis and melatonin in humans: possible interactions in the control of body temperature. Mazzoccoli G; Giuliani A; Carughi S; De Cata A; Puzzolante F; La Viola M; Urbano N; Perfetto F; Tarquini R Neuro Endocrinol Lett; 2004 Oct; 25(5):368-72. PubMed ID: 15580172 [TBL] [Abstract][Full Text] [Related]
36. Biochemotherapy with immunomodulating pineal hormones other than melatonin: 5-methoxytryptamine as a new oncostatic pineal agent. Lissoni P Pathol Biol (Paris); 2007; 55(3-4):198-200. PubMed ID: 17451889 [TBL] [Abstract][Full Text] [Related]
37. Total pineal endocrine substitution therapy (TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic solid tumor patients: a phase II study. Lissoni P; Malugani F; Brivio F; Piazza A; Vintimilla C; Giani L; Tancini G Neuro Endocrinol Lett; 2003; 24(3-4):259-62. PubMed ID: 14523367 [TBL] [Abstract][Full Text] [Related]
38. Tamoxifen: 28-day oral toxicity study in the rat based on the Enhanced OECD Test Guideline 407 to detect endocrine effects. Kennel P; Pallen C; Barale-Thomas E; Espuña G; Bars R Arch Toxicol; 2003 Sep; 77(9):487-99. PubMed ID: 12802581 [TBL] [Abstract][Full Text] [Related]
39. The effects of malathion on some hormone levels and tissues secreting these hormones in rats. Ozmen G; Akay MT Vet Hum Toxicol; 1993 Feb; 35(1):22-4. PubMed ID: 8434444 [TBL] [Abstract][Full Text] [Related]